Thus, in the third cycle, GnRH-a was used for down-regulation in order to increase the sensitivity of hypophysis, and r-FSH was then added for ovulation induction, but unfortunately, there was still no dominant follicular development. The gene discussed is BRD2; the disease is hypophysitis.